1. Home
  2. WILC vs MYGN Comparison

WILC vs MYGN Comparison

Compare WILC & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WILC

G. Willi-Food International Ltd.

HOLD

Current Price

$36.07

Market Cap

487.6M

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$3.68

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WILC
MYGN
Founded
1994
1991
Country
Israel
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
487.6M
444.2M
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
WILC
MYGN
Price
$36.07
$3.68
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$7.64
AVG Volume (30 Days)
3.0K
1.4M
Earning Date
05-18-2026
05-05-2026
Dividend Yield
2.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
N/A
$5.45
P/E Ratio
$13.45
N/A
Revenue Growth
N/A
2.33
52 Week Low
$15.30
$3.75
52 Week High
$36.90
$8.59

Technical Indicators

Market Signals
Indicator
WILC
MYGN
Relative Strength Index (RSI) 68.27 30.29
Support Level $26.29 N/A
Resistance Level N/A $5.30
Average True Range (ATR) 1.27 0.28
MACD 0.25 -0.12
Stochastic Oscillator 77.82 0.00

Price Performance

Historical Comparison
WILC
MYGN

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is an Israeli-based company specializing in high-quality, great-tasting kosher food products. The company is engaged, directly and through subsidiaries, in the design, import, marketing and distribution of a variety of over 650 food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Cereals, rice and pastas, and Other Products. The company has one reportable segment: Import- export, marketing and distribution of food products. The majority of the company's revenue is derived from the sale of Dairy and Dairy Substitute Products.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: